Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0
Theaflavin gallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 2 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 20 10